Theranos Inc. faces controversy once again as a new lab study shows that the blood test results provided by the firm are not within the normal range. The company responded with a letter addressed to the journal which will publish the study on May.
Theranos Inc. faces controversy once again as a new lab study shows that the blood test results provided by the firm are not within the normal range. The company responded with a letter addressed to the journal which will publish the study on May.
Share this Article
Comment on this Article
Recommended
Please to comment